US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,947.58

+9.800.33%

Number of Gainers:2

Number of Losers:3

Number of Flat:- -

PE:- -

High:2,972.09

Open:2,940.26

Low:2,930.55

Close:2,937.78

Volume:2.10M

Turnover:51.24M

Market Cap:49.13B

Float Cap:45.86B

Loading ...

Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates

MT Newswires Live

MannKind (MNKD) Jumps On Fresh Momentum As Fair Value Stays In Focus

Simply Wall St.

Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

NYSE Order Imbalance 18799.0 Shares on Buy Side

THOMSON REUTERS

Teva Reports FDA Approval for Degevma

MT Newswires Live

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Pharmaceutical's Duvakitug Could be Validated by Merck's Tulisokibart Results, Oppenheimer Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/stock/BK4584/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2947.584,"timestamp":1791902630541,"preClose":2937.783,"halted":0,"volume":2095778,"delay":0,"changeRate":0.003336,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":9.801025,"latestTime":"10-13 10:43:51 EDT","open":2940.264,"high":2972.0889,"low":2930.5452,"amount":51235010.423085,"amplitude":0.014141,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.35238,"peRate":78.312631,"turnoverRate":0.001457,"increases":2,"decrements":3,"flats":0,"marketCap":49127553560,"floatMarketCap":45864631750},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2972.0889,"amplitude":0.014141,"preClose":2937.783,"low":2930.5452,"pbRate":"6.35238","latestPrice":2947.584,"volume":2095810,"delay":0,"open":2940.264,"prevYearClose":2379.9924,"prevWeekClose":2937.559,"prevMonthClose":2843.1685,"prevQuarterClose":2843.1685,"fiveDayClose":2807.4763,"twentyDayClose":2812.2063,"sixtyDayClose":2345.0417,"secType":"PLATE","market":"US","turnoverRate":0.001457,"peRate":78.312631,"marketCap":49127553560,"floatMarketCap":45864631750,"timestamp":1791902632083,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":2,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672919755","title":"Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2672919755","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672919755?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:30","pubTimestamp":1790847036,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  has entered into an agreement with Samsung Bioepis for the global licensing, development, and commercialization of up to six potential biosimilar candidates, the companies said on Thursday.Under the deal, South Korea's Samsung Bioepis will manage the development, regulatory registration, and making of the biosimilars. Meanwhile, Teva will be in charge of commercialization in global markets, including the US, Europe, and Canada, with an option to expand to other territories, Teva said.The companies have confirmed two investigational biosimilar candidates, SB41, referencing Fasenra and SB44, referencing Ilaris, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983299246.USD","BK4566","BK4557","TEVA","BK4585","BK4007","EMXC","LU2324357040.USD","IEMG","BK4559","BK4584","BK4596","BK4550","BK4504","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672730503","title":"MannKind (MNKD) Jumps On Fresh Momentum As Fair Value Stays In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2672730503","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672730503?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:12","pubTimestamp":1790831535,"startTime":"0","endTime":"0","summary":"MannKind (MNKD) has drawn fresh attention after a sharp 16.8% one day gain, followed by an 18.5% advance over the past week, raising questions about what this move implies for recent underperformance.\nThat surge comes after a tougher spell for MannKind, with the share price still down 30.4% year to date and the 1-year total shareholder return lower by 29%. The latest bounce hints at improving sentiment rather than a fully repaired long-term track record.\nScan MannKind’s sharp move despite its...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/mannkind-mnkd-jumps-on-fresh-momentum-as-fair-value-stays-in","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/mannkind-mnkd-jumps-on-fresh-momentum-as-fair-value-stays-in","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4584","BK4139","MNKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782213","title":"Press Release: TAPI (Technology & API Services) Names Serge Rogasik CEO to Lead Next Chapter of Growth and Competitiveness","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782213","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782213?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:32","pubTimestamp":1790800320,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) -- TAPI (Technology & API Services) today announced the appointment of Serge Rogasik as its Chief Executive Officer. Mr. Rogasik will lead a global bu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBB","BK4596","OTX.SI","BK4584","LU1983299246.USD","TEVA","BK4557","LU2324357040.USD","BK4585","BK4588","BK6520","BK6100","BK4566","BK4007","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789452","title":"Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789452?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:10","pubTimestamp":1790788218,"startTime":"0","endTime":"0","summary":"Liquidia’s (LQDA) Yutrepia faces a Delaware court finding of infringement of United Therapeutics’ (UTHR) ‘327 patent, pressuring Liquidia shares bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liquidia-ruling-has-positive-read-through-for-mannkind-tyvaso-dpi-says-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liquidia-ruling-has-positive-read-through-for-mannkind-tyvaso-dpi-says-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1699723380.USD","BK4139","BK4007","BK4584","LU1571399168.USD","USRD","UTHR","MNKD","BK4532","LQDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671724230","title":"NYSE Order Imbalance 18799.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2671724230","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671724230?lang=en_us&edition=fundamental","pubTime":"2026-09-30 03:50","pubTimestamp":1790711402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nAQN2MLD8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU1983299246.USD","BK4559","BK4596","BK4588","BK4584","BK4557","TEVA","LU2324357040.USD","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250803","title":"Teva Reports FDA Approval for Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250803","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250803?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:25","pubTimestamp":1790627151,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said late Monday the US Food and Drug Administration has approved Degevma as a biosimilar to Xgeva.Degevma is indicated for the prevention of bone complications in adults with advanced cancer that has spread to the bone, it said.The drug is also indicated for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone and for the treatment of hypercalcemia of malignancy, Teva said.Teva said it expects to launch Degevma and Ponlimsi in the US in the coming months. Ponlimsi was approved in March.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","BK4557","BK4588","BK4566","BK4596","BK4007","BK4584","LU1983299246.USD","TEVA","BK4559","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1983299246.USD","GNMX","TBXU","BK4584","FRTY","NVIB","MRNY","GDOC","MRNX","BMED","BK4007","IEIH","BK4585","LFSC","SYNB","BK4596","BK4557","RSPH","BK4559","IDNA","BBP","IBB","TEVA","BK4588","PINK","LU2324357040.USD","LABU","MEDI","PSCH","XLVX","BK4566","TECB","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670525939","title":"Teva Pharmaceutical's Duvakitug Could be Validated by Merck's Tulisokibart Results, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670525939","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670525939?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:49","pubTimestamp":1790610591,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical's (TEVA) Duvakitug inflammatory bowel disease drug could be validated by Merck's (MRK) upcoming Tulisokibart results, Oppenheimer said in a Friday note.Analysts said that the best ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0823416689.USD","LU0106261372.USD","LU0265550946.USD","BK4557","LU0122379950.USD","LU0289739343.SGD","LU1037948541.HKD","LU2433249047.HKD","SG9999001176.SGD","LU0289961442.SGD","LU1066051225.USD","IYH","LU0057025933.USD","LU1093756325.SGD","SG9999014542.SGD","IHE","IE00BJT1NW94.SGD","IE000M9KFDE8.USD","LU2491049909.HKD","BK4550","LU0965508806.USD","TRUH","BK4534","LU0070302665.USD","LU0511384066.AUD","LU0006306889.USD","LU2357627491.SGD","IE00BJJMRZ35.SGD","LU2360032135.SGD","LU2491050071.SGD","LU0980610538.SGD","GDOC","SG9999002224.SGD","IE00BLSP4452.SGD","BK4596","LU1162221912.USD","LU1699723380.USD","LU2125909247.SGD","LU1093756168.USD","LU2112291526.USD","SG9999015358.SGD","LU1116320901.HKD","LU1929549753.HKD","LU0265550359.USD","IE00BLSP4239.USD","LU0124676726.USD","LU0861579265.USD","LU1934455863.HKD","LU1032466523.USD","LU0058720904.USD","LU1430594728.SGD","LU0289739699.SGD","LU1061106388.HKD","LU2023250843.SGD","LU2125154935.USD","LU1066051498.USD","XLV","LU0472753341.HKD","LU1023059063.AUD","LU2361045086.USD","LU0648001328.SGD","LU0868494708.USD","SG9999001440.SGD","LU0211331839.USD","LU1201861249.SGD","LU0689626769.HKD","SG9999002232.USD","LU1291159041.SGD","LU0942090050.USD","LU1989772923.USD","LU2125154778.USD","LU2361044949.HKD","SGXZ57979304.SGD","LU1934455277.USD","LU0965509101.SGD","PPH","LU1066051811.HKD","BK4007","MRK","LU1069347547.HKD","IE0009355771.USD","LU1571399168.USD","BK4566","LU0320765646.SGD","IE00BBT3K403.USD","IE0002141913.USD","RXL","SG9999014567.USD","IE00BN8TJ469.HKD","LU0098860793.USD","HRTS","PAWZ","VHT","LU0072461881.USD","LU1941712348.USD","SG9999014559.SGD","LU0432979614.USD","LU0208291251.USD","LU0162691827.USD","FHLC","BK4585","JDOC","LU0985320562.USD","LU0965509010.AUD","LU1037948897.HKD","LU1974910355.USD","LU0238689110.USD","FTXH","LU1585245621.USD","LU1917777945.USD","LU1923622614.USD","LU1035773651.USD","LU0130517989.USD","IE00B4R5TH58.HKD","LU1934455194.USD","BK4588","LU0203345920.USD","LU0266013472.USD","LU2106854487.HKD","LU0234572021.USD","IE00B2B36J28.USD","LU1983299246.USD","LU2324357040.USD","LU0130102774.USD","SG9999014575.USD","LU2468319806.SGD","LU2361044865.SGD","LU1989771016.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU0965509283.SGD","LU0320765489.SGD","LU0069063385.USD","BK4533","IXJ","LU0859254822.USD","LU2491050154.USD","LU0868494617.USD","BK4516","LU1066053197.SGD","BK4559","SG9999001176.USD","BMED","TEVA","LU2089984988.USD","LU2461242641.AUD","LU1057294990.SGD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","BK4584","SG9999013999.USD","LU1116320737.USD","LU0203347892.USD","LU2125909593.SGD","LU1941712264.USD","LU1989772840.SGD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":28,"code":"91000000","status":"200"}]}}